An inactivating mutation of the RHOA gene encoding a p.Gly17Val is present in ~70% of AITL, whereas it is present in only 18% of other T-Cell lymphomas with a TFH phenotype and is very rare in other peripheral T-Cell lymphomas [4,38]. The gene discussed is RHOA; the disease is angioimmunoblastic T-cell lymphoma.